Astera Labs, Inc. $ALAB Shares Sold by Pacer Advisors Inc.

Pacer Advisors Inc. trimmed its stake in Astera Labs, Inc. (NASDAQ:ALAB) by 24.4% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 388,078 shares of the company’s stock after selling 125,074 shares during the quarter. Pacer Advisors Inc.’s holdings in Astera Labs were worth $64,561,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Eurizon Capital SGR S.p.A. purchased a new stake in Astera Labs during the fourth quarter worth approximately $18,708,000. Nordea Investment Management AB purchased a new position in shares of Astera Labs in the 4th quarter valued at $2,028,000. Geneva Partners LLC purchased a new position in shares of Astera Labs in the 3rd quarter valued at $1,876,000. Numerai GP LLC lifted its holdings in shares of Astera Labs by 153.1% during the 3rd quarter. Numerai GP LLC now owns 13,212 shares of the company’s stock valued at $2,587,000 after acquiring an additional 7,992 shares in the last quarter. Finally, Swedbank AB lifted its holdings in shares of Astera Labs by 76.8% during the 4th quarter. Swedbank AB now owns 78,140 shares of the company’s stock valued at $12,999,000 after acquiring an additional 33,940 shares in the last quarter. Institutional investors and hedge funds own 60.47% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on ALAB. Rothschild & Co Redburn assumed coverage on Astera Labs in a report on Friday, May 1st. They issued a “neutral” rating and a $153.00 price target for the company. Northland Securities cut Astera Labs from an “outperform” rating to a “market perform” rating in a research note on Tuesday, May 26th. Royal Bank Of Canada upped their target price on Astera Labs from $250.00 to $270.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 6th. Roth Mkm reiterated a “buy” rating and issued a $275.00 target price on shares of Astera Labs in a research note on Wednesday, May 6th. Finally, Stifel Nicolaus raised their target price on Astera Labs from $236.00 to $260.00 and gave the company a “buy” rating in a report on Wednesday, May 6th. Twelve research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $233.75.

Astera Labs Trading Up 11.3%

Shares of ALAB stock opened at $417.07 on Friday. The firm has a fifty day simple moving average of $258.60 and a 200-day simple moving average of $185.72. The company has a market capitalization of $71.49 billion, a PE ratio of 281.80, a price-to-earnings-growth ratio of 4.96 and a beta of 3.95. Astera Labs, Inc. has a twelve month low of $84.78 and a twelve month high of $421.20.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The firm had revenue of $308.36 million for the quarter, compared to the consensus estimate of $292.19 million. During the same quarter in the previous year, the firm posted $0.33 EPS. The firm’s quarterly revenue was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Equities research analysts predict that Astera Labs, Inc. will post 1.84 EPS for the current year.

Insider Activity at Astera Labs

In related news, COO Sanjay Gajendra sold 400,000 shares of the business’s stock in a transaction dated Thursday, May 21st. The stock was sold at an average price of $290.30, for a total value of $116,120,000.00. Following the transaction, the chief operating officer owned 5,064,213 shares in the company, valued at approximately $1,470,141,033.90. The trade was a 7.32% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Philip Mazzara sold 796 shares of the stock in a transaction dated Thursday, May 21st. The shares were sold at an average price of $291.03, for a total value of $231,659.88. Following the completion of the transaction, the general counsel directly owned 103,343 shares of the company’s stock, valued at $30,075,913.29. This represents a 0.76% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 2,161,256 shares of company stock valued at $459,844,296. 10.40% of the stock is currently owned by insiders.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.